4//SEC Filing
Pamukcu Rifat 4
Accession 0001104659-25-057818
CIK 0001781983other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:06 PM ET
Size
8.2 KB
Accession
0001104659-25-057818
Insider Transaction Report
Form 4
Pamukcu Rifat
Director
Transactions
- Award
Common Stock
2025-06-05+1,045→ 5,446 total - Award
Stock Options (Right to Buy)
2025-06-05+4,185→ 4,185 totalExercise: $1.81Exp: 2035-06-05→ Common Stock (4,185 underlying)
Holdings
- 14,108(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]The Reporting Person serves as Manager Partner of ZNZ Holdings L.L.C.
- [F3]The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001929298
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:06 PM ET
- Size
- 8.2 KB